1 Market Overview

1.1 Product Overview and Scope of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy

1.2 Classification of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Type

1.2.1 Overview: Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Type in 2020

1.2.3 Allogeneic CAR T-Cells

1.2.4 Autologous CAR T-Cells

1.3 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market by Application

1.3.1 Overview: Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Hospital

1.3.3 Diagnostic Center

1.3.4 Others

1.4 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size & Forecast

1.5 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Forecast by Region

1.5.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Region, (2016-2021)

1.5.3 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Prospect (2016-2026)

1.5.4 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Prospect (2016-2026)

1.5.6 South America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Drivers

1.6.2 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Restraints

1.6.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Trends Analysis

2 Company Profiles

2.1 Pfizer

2.1.1 Pfizer Details

2.1.2 Pfizer Major Business

2.1.3 Pfizer Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Solutions

2.1.4 Pfizer Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Pfizer Recent Developments and Future Plans

2.2 Novartis

2.2.1 Novartis Details

2.2.2 Novartis Major Business

2.2.3 Novartis Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Solutions

2.2.4 Novartis Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Novartis Recent Developments and Future Plans

2.3 Bristol Myers Squibb

2.3.1 Bristol Myers Squibb Details

2.3.2 Bristol Myers Squibb Major Business

2.3.3 Bristol Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Solutions

2.3.4 Bristol Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Bristol Myers Squibb Recent Developments and Future Plans

2.4 Legend Biotech

2.4.1 Legend Biotech Details

2.4.2 Legend Biotech Major Business

2.4.3 Legend Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Solutions

2.4.4 Legend Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Legend Biotech Recent Developments and Future Plans

2.5 Sorrento Therapeutics

2.5.1 Sorrento Therapeutics Details

2.5.2 Sorrento Therapeutics Major Business

2.5.3 Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Solutions

2.5.4 Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Sorrento Therapeutics Recent Developments and Future Plans

2.6 CARSGEN Therapeutics，Ltd

2.6.1 CARSGEN Therapeutics，Ltd Details

2.6.2 CARSGEN Therapeutics，Ltd Major Business

2.6.3 CARSGEN Therapeutics，Ltd Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Solutions

2.6.4 CARSGEN Therapeutics，Ltd Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 CARSGEN Therapeutics，Ltd Recent Developments and Future Plans

2.7 Juno Therapeutics

2.7.1 Juno Therapeutics Details

2.7.2 Juno Therapeutics Major Business

2.7.3 Juno Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Solutions

2.7.4 Juno Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Juno Therapeutics Recent Developments and Future Plans

2.8 Kite Pharma

2.8.1 Kite Pharma Details

2.8.2 Kite Pharma Major Business

2.8.3 Kite Pharma Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Solutions

2.8.4 Kite Pharma Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Kite Pharma Recent Developments and Future Plans

2.9 Atara Biotherapeutics

2.9.1 Atara Biotherapeutics Details

2.9.2 Atara Biotherapeutics Major Business

2.9.3 Atara Biotherapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Solutions

2.9.4 Atara Biotherapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Atara Biotherapeutics Recent Developments and Future Plans

2.10 Carina Biotech

2.10.1 Carina Biotech Details

2.10.2 Carina Biotech Major Business

2.10.3 Carina Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Solutions

2.10.4 Carina Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Carina Biotech Recent Developments and Future Plans

2.11 Guangzhou Xiangxue Pharmaceutical

2.11.1 Guangzhou Xiangxue Pharmaceutical Details

2.11.2 Guangzhou Xiangxue Pharmaceutical Major Business

2.11.3 Guangzhou Xiangxue Pharmaceutical Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Solutions

2.11.4 Guangzhou Xiangxue Pharmaceutical Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Guangzhou Xiangxue Pharmaceutical Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Players Market Share

3.2.2 Top 10 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Players Market Share

3.2.3 Market Competition Trend

3.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue and Market Share by Type (2016-2021)

4.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Application (2016-2021)

5.2 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Type (2016-2026)

6.2 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Application (2016-2026)

6.3 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country

6.3.1 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Country (2016-2026)

6.3.2 United States Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Forecast (2016-2026)

6.3.3 Canada Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Forecast (2016-2026)

6.3.4 Mexico Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Type (2016-2026)

7.2 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Application (2016-2026)

7.3 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country

7.3.1 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Country (2016-2026)

7.3.2 Germany Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Forecast (2016-2026)

7.3.3 France Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Forecast (2016-2026)

7.3.5 Russia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Forecast (2016-2026)

7.3.6 Italy Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Type (2016-2026)

8.2 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Application (2016-2026)

8.3 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Region

8.3.1 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Region (2016-2026)

8.3.2 China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Forecast (2016-2026)

8.3.3 Japan Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Forecast (2016-2026)

8.3.4 South Korea Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Forecast (2016-2026)

8.3.5 India Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Forecast (2016-2026)

8.3.7 Australia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Type (2016-2026)

9.2 South America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Application (2016-2026)

9.3 South America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country

9.3.1 South America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Country (2016-2026)

9.3.2 Brazil Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Forecast (2016-2026)

9.3.3 Argentina Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Type (2016-2026)

10.2 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Application (2016-2026)

10.3 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country

10.3.1 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Country (2016-2026)

10.3.2 Turkey Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Forecast (2016-2026)

10.3.4 UAE Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (USD Million) by Region (2016-2021)

Table 5. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Region (2021-2026)

Table 6. Pfizer Corporate Information, Head Office, and Major Competitors

Table 7. Pfizer Major Business

Table 8. Pfizer Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Solutions

Table 9. Pfizer Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Novartis Corporate Information, Head Office, and Major Competitors

Table 11. Novartis Major Business

Table 12. Novartis Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Solutions

Table 13. Novartis Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Bristol Myers Squibb Corporate Information, Head Office, and Major Competitors

Table 15. Bristol Myers Squibb Major Business

Table 16. Bristol Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Solutions

Table 17. Bristol Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Legend Biotech Corporate Information, Head Office, and Major Competitors

Table 19. Legend Biotech Major Business

Table 20. Legend Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Solutions

Table 21. Legend Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Sorrento Therapeutics Corporate Information, Head Office, and Major Competitors

Table 23. Sorrento Therapeutics Major Business

Table 24. Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Solutions

Table 25. Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. CARSGEN Therapeutics，Ltd Corporate Information, Head Office, and Major Competitors

Table 27. CARSGEN Therapeutics，Ltd Major Business

Table 28. CARSGEN Therapeutics，Ltd Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Solutions

Table 29. CARSGEN Therapeutics，Ltd Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Juno Therapeutics Corporate Information, Head Office, and Major Competitors

Table 31. Juno Therapeutics Major Business

Table 32. Juno Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Solutions

Table 33. Juno Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Kite Pharma Corporate Information, Head Office, and Major Competitors

Table 35. Kite Pharma Major Business

Table 36. Kite Pharma Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Solutions

Table 37. Kite Pharma Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Atara Biotherapeutics Corporate Information, Head Office, and Major Competitors

Table 39. Atara Biotherapeutics Major Business

Table 40. Atara Biotherapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Solutions

Table 41. Atara Biotherapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Carina Biotech Corporate Information, Head Office, and Major Competitors

Table 43. Carina Biotech Major Business

Table 44. Carina Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Solutions

Table 45. Carina Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Guangzhou Xiangxue Pharmaceutical Corporate Information, Head Office, and Major Competitors

Table 47. Guangzhou Xiangxue Pharmaceutical Major Business

Table 48. Guangzhou Xiangxue Pharmaceutical Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Solutions

Table 49. Guangzhou Xiangxue Pharmaceutical Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (USD Million) by Players (2019-2021)

Table 51. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Share by Players (2019-2021)

Table 52. Breakdown of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Company Type (Tier 1, Tier 2 and Tier 3)

Table 53. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Players Head Office, Products and Services Provided

Table 54. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Mergers & Acquisitions in the Past Five Years

Table 55. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy New Entrants and Expansion Plans

Table 56. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (USD Million) by Type (2016-2021)

Table 57. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Share by Type (2016-2021)

Table 58. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Forecast by Type (2021-2026)

Table 59. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Application (2016-2021)

Table 60. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Forecast by Application (2021-2026)

Table 61. North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Type (2016-2021) & (USD Million)

Table 62. North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Type (2021-2026) & (USD Million)

Table 63. North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Application (2016-2021) & (USD Million)

Table 64. North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Application (2021-2026) & (USD Million)

Table 65. North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Country (2016-2021) & (USD Million)

Table 66. North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Country (2021-2026) & (USD Million)

Table 67. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Type (2016-2021) & (USD Million)

Table 68. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Type (2021-2026) & (USD Million)

Table 69. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Application (2016-2021) & (USD Million)

Table 70. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Application (2021-2026) & (USD Million)

Table 71. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Country (2016-2021) & (USD Million)

Table 72. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Country (2021-2026) & (USD Million)

Table 73. Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Type (2016-2021) & (USD Million)

Table 74. Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Type (2021-2026) & (USD Million)

Table 75. Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Application (2016-2021) & (USD Million)

Table 76. Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Application (2021-2026) & (USD Million)

Table 77. Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Region (2016-2021) & (USD Million)

Table 78. Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Region (2021-2026) & (USD Million)

Table 79. South America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Type (2016-2021) & (USD Million)

Table 80. South America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Type (2021-2026) & (USD Million)

Table 81. South America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Application (2016-2021) & (USD Million)

Table 82. South America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Application (2021-2026) & (USD Million)

Table 83. South America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Country (2016-2021) & (USD Million)

Table 84. South America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Country (2021-2026) & (USD Million)

Table 85. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Type (2016-2021) & (USD Million)

Table 86. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Type (2021-2026) & (USD Million)

Table 87. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Application (2016-2021) & (USD Million)

Table 88. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Application (2021-2026) & (USD Million)

Table 89. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Country (2016-2021) & (USD Million)

Table 90. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Picture

Figure 2. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Type in 2020

Figure 3. Allogeneic CAR T-Cells

Figure 4. Autologous CAR T-Cells

Figure 5. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Application in 2020

Figure 6. Hospital Picture

Figure 7. Diagnostic Center Picture

Figure 8. Others Picture

Figure 9. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 10. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue and Forecast (2016-2026) & (USD Million)

Figure 11. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Region (2016-2026)

Figure 12. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Region in 2020

Figure 13. North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (USD Million) and Growth Rate (2016-2026)

Figure 14. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (USD Million) and Growth Rate (2016-2026)

Figure 15. Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. South America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Drivers

Figure 19. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Restraints

Figure 20. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Trends

Figure 21. Pfizer Recent Developments and Future Plans

Figure 22. Novartis Recent Developments and Future Plans

Figure 23. Bristol Myers Squibb Recent Developments and Future Plans

Figure 24. Legend Biotech Recent Developments and Future Plans

Figure 25. Sorrento Therapeutics Recent Developments and Future Plans

Figure 26. CARSGEN Therapeutics，Ltd Recent Developments and Future Plans

Figure 27. Juno Therapeutics Recent Developments and Future Plans

Figure 28. Kite Pharma Recent Developments and Future Plans

Figure 29. Atara Biotherapeutics Recent Developments and Future Plans

Figure 30. Carina Biotech Recent Developments and Future Plans

Figure 31. Guangzhou Xiangxue Pharmaceutical Recent Developments and Future Plans

Figure 32. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Share by Players in 2020

Figure 33. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 34. Global Top 3 Players Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share in 2020

Figure 35. Global Top 10 Players Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share in 2020

Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 37. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Share by Type in 2020

Figure 38. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share Forecast by Type (2021-2026)

Figure 39. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Share by Application in 2020

Figure 40. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share Forecast by Application (2021-2026)

Figure 41. North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Market Share by Type (2016-2026)

Figure 42. North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Market Share by Application (2016-2026)

Figure 43. North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Country (2016-2026)

Figure 44. United States Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 45. Canada Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 46. Mexico Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 47. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Market Share by Type (2016-2026)

Figure 48. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Market Share by Application (2016-2026)

Figure 49. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Country (2016-2026)

Figure 50. Germany Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. France Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. United Kingdom Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 53. Russia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. Italy Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Market Share by Type (2016-2026)

Figure 56. Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Market Share by Application (2016-2026)

Figure 57. Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Region (2016-2026)

Figure 58. China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Japan Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. South Korea Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. India Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. Southeast Asia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Australia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. South America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Market Share by Type (2016-2026)

Figure 65. South America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Market Share by Application (2016-2026)

Figure 66. South America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Country (2016-2026)

Figure 67. Brazil Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. Argentina Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Market Share by Type (2016-2026)

Figure 70. Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Market Share by Application (2016-2026)

Figure 71. Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Country (2016-2026)

Figure 72. Turkey Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Saudi Arabia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. UAE Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. Methodology

Figure 76. Research Process and Data Source